Europe DNA Extraction, Isolation, and Purification Market Forecast to 2030 - Regional Analysis - by Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and

Europe DNA Extraction, Isolation, and Purification Market Forecast to 2030 - Regional Analysis - by Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and Microbial DNA), Application [PCR Test, Next Generation Sequencing (NGS), Microarray, and Others], and End User (Hospitals, Diagnostic Centers and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others)

The Europe DNA extraction, isolation, and purification market was valued at US$ 667.31 million in 2022 and is expected to reach US$ 1,303.96 million by 2030; it is estimated to grow at a CAGR of 8.7% from 2022 to 2030.

Rising R&D in Genomics Fuels the Europe DNA Extraction, Isolation, and Purification Market

Genomics holds significant potential for improved diagnostics and treatment of genetic diseases. Genomic DNA extraction is one of the most common procedures in the life sciences. Genomic DNA contains all of an organism's genetic and chromosomal material and encodes all of the components required for life. The emergence of cutting-edge technologies for sequencing, and assembly and analysis of sequenced data is likely to strengthen the importance of genomics in medicine and other branches of science. Thus, government and nongovernment agencies are taking initiatives to boost genomic research. In December 2022, the Government of UK announced funding to support projects focusing on building the world's most advanced genomic healthcare system and improve health outcomes in the country. The funding enabled researchers to provide world-class genomic healthcare, which involves the study of people's DNA as a core job.

Europe DNA Extraction, Isolation, and Purification Market Overview

The DNA extraction, isolation, and purification market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. According to the International Trade Administration (ITA), the German medical device market accounts for ~US$ 35.8 billion annually, and it occupies ~25.6% of the total European medical device market. As per ITA, Germany ranks third among the largest medical technology markets in the world, after the US and Japan, and by far, the largest European market. According to the World Cancer Research Fund (WCRF) International, Germany had a significant incidence age-standardized rate of 281.9 cancer cases per 100,000 in 2020 as the country recorded 538,140 new cases. GLOBOCAN 2020 stated that Germany has a high prevalence rate of breast, prostate, lung, and colorectum cancer. Thus, the rising health awareness due to the elevating prevalence of chronic diseases such as cancer triggers the demand for diagnostics systems in Germany, which benefits the DNA extraction, isolation, and purification market. The Office for National Statistics (ONS) reported that population in the UK is expected to reach 69.2 million by mid-2030 from 67.1 million in 2021, recording an expansion of 2.1 million at a rate of 3.2% during 2020-2030. The population growth would reflect a subsequent increase in the prevalence of diseases, genetic disorders, and cancer cases, resulting in higher demand for diagnostics. According to the WCRF International, the UK had a significant incidence age-standardized rate of 296.1 cancer cases per 100,000, with 409,228 new cases in 2020. As per Gene People UK (Genetic Disorders UK), ~1 in 25 children (4%) is affected by a genetic condition, which means 30,000 infants and children are newly diagnosed with genetic disorders in the UK annually. According to the Global Burden of Disease (GBD) data published in 2020, over the past decades, France has reported the most deaths due to ischemic heart disease, Alzheimer's disease, stroke, lung cancer, and chronic obstructive pulmonary disease (COPD). As per the WCRF International, the country had a significant incidence age-standardized rate of 320.1 cancer cases per 100,000, with 422,828 new cases, in 2020. Thus, high cancer prevalence rates and the highly productive medical device industry trigger the demand for DNA extraction, isolation, and purification methods in Europe.

Europe DNA Extraction, Isolation, and Purification Market Revenue and Forecast to 2030 (US$ Million)

Europe DNA Extraction, Isolation, and Purification Market Segmentation

The Europe DNA extraction, isolation, and purification market is segmented based on type, method, sample type, source, application, end user, and country.

Based on type, the Europe DNA extraction, isolation, and purification market is categorized into Kits, instrument, and reagent. The kits segment held the largest Europe DNA extraction, isolation, and purification market share in 2022.

In terms of method, the Europe DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held a larger Europe DNA extraction, isolation, and purification market share in 2022. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.

By sample type, the Europe DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held the largest Europe DNA extraction, isolation, and purification market share in 2022.

By source, the Europe DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held a larger Europe DNA extraction, isolation, and purification market share in 2022. The microbial segment is further subsegmented into bacteria and virus.

Based on application, the Europe DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held the largest Europe DNA extraction, isolation, and purification market share in 2022. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.

By end-user, the Europe DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held the largest Europe DNA extraction, isolation, and purification market share in 2022.

Based on country, the Europe DNA extraction, isolation, and purification market is categorized into the UK, Germany, France, Italy, Spain, Benelux, Austria, and the Rest of Europe. The UK dominated the Europe DNA extraction, isolation, and purification market in 2022.

Bio-Rad Laboratories Inc, Danaher Corp, GE HealthCare Technologies Inc, F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Qiagen NV, Merck KGaA, Illumina Inc, Takara Bio Inc, Thermo Fisher Scientific Inc, and Molzym GmbH & Co KG are some of the leading companies operating in the Europe DNA extraction, isolation, and purification market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe DNA extraction, isolation, and purification market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe DNA extraction, isolation, and purification market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the DNA extraction, isolation, and purification market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution